Huang Xin-Miao, Hu Jian-Qiang, Zhou Fei, Qin Yong-Wen, Cao Jiang, Zhou Bing-Yan, Zhao Xian-Xian, Zheng Xing
Department of Cardiovascular Diseases, Changhai Hospital, Second Military Medical University, Shanghai, China.
Pacing Clin Electrophysiol. 2011 Jan;34(1):9-14. doi: 10.1111/j.1540-8159.2010.02938.x. Epub 2010 Oct 28.
With the number of complex catheter ablation procedures increasing, procedure-related acute cardiac tamponade is encountered more frequently in the cardiac catheterization laboratory. Survival depends on prompt recognition and rescue pericardiocentesis.
The aim of this report was to validate fluoroscopic heart silhouette characteristics associated with cardiac tamponade as a diagnostic method, and evaluate the safety and effectiveness of fluoroscopy-guided pericardiocentesis during catheter ablation.
All cases of acute cardiac tamponade that occurred in the cardiac catheterization laboratory during radiofrequency catheter ablation from March 2004 to November 2009 were reviewed retrospectively.
Of 1,832 catheter ablation procedures performed during a 5-year period, 10 (0.55%) were complicated by cardiac tamponade. Fluoroscopic examination confirmed the diagnosis in all 10 patients and demonstrated effusions before hypotension in four patients. All patients were stabilized by fluoroscopy-guided pericardiocentesis with placement of an indwelling catheter and autologous transfusion. The time interval between recognition of cardiac tamponade and completion of pericardiocentesis was 6.0 ± 1.8 minutes (range 3-9 minutes). The mean aspirated blood volume was 437 mL (range 110-1,400 mL), and the mean autotransfused blood volume was 425 mL (range 100-1,384 mL). Surgical repair of the cardiac perforation was needed in one patient. No procedure-related death occurred.
A reduction in the excursion of cardiac silhouette on fluoroscopy is an early diagnostic sign of cardiac tamponade during radiofrequency ablation. Fluoroscopy-guided pericardiocentesis is a safe and effective management strategy for cardiac tamponade developed in the cardiac catheterization laboratory.
随着复杂导管消融手术数量的增加,心脏导管室中与手术相关的急性心脏压塞更为常见。生存取决于及时识别和进行心包穿刺引流。
本报告旨在验证与心脏压塞相关的透视下心影特征作为一种诊断方法,并评估导管消融期间透视引导下心包穿刺术的安全性和有效性。
回顾性分析2004年3月至2009年11月在心脏导管室进行射频导管消融期间发生的所有急性心脏压塞病例。
在5年期间进行的1832例导管消融手术中,10例(0.55%)并发心脏压塞。透视检查在所有10例患者中均确诊,并在4例患者低血压前显示有积液。所有患者通过透视引导下心包穿刺术并留置导管和自体输血后病情稳定。从识别心脏压塞到完成心包穿刺术的时间间隔为6.0±1.8分钟(范围3 - 9分钟)。平均抽出的血液量为437 mL(范围110 - 1400 mL),平均自体回输的血液量为425 mL(范围100 - 1384 mL)。1例患者需要进行心脏穿孔的手术修复。未发生与手术相关的死亡。
透视下心影活动度降低是射频消融期间心脏压塞的早期诊断征象。透视引导下心包穿刺术是心脏导管室中治疗心脏压塞的一种安全有效的管理策略。